He, Hongbo

Blood pressure‐lowering effects of GLP ‐1 receptor agonists exenatide and liraglutide: a meta‐analysis of clinical trials

Wang, B., Zhong, J., Lin, H., Zhao, Z., Yan, Z., He, H., Ni, Y., Liu, D., & Zhu, Z. (2013) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementBlood Pressure and Hypertension Studies

Cited by 225

Altered Serum Levels of TNF-α, IL-6, and IL-18 in Depressive Disorder Patients

Fan, N., Luo, Y., Ou, Y., & He, H. (2017) · Human Psychopharmacology: Clinical and Experimental

Tryptophan and brain disordersTreatment of Major Depression

Cited by 85

Activation of glucagon-like peptide-1 receptor ameliorates cognitive decline in type 2 diabetes mellitus through a metabolism-independent pathway

Li, Q., Jia, M., Yan, Z., Li, Q., Sun, F., He, C., Li, Y., Zhou, X., Zhang, H., Liu, X., et al. (2021) · Journal of the American Heart Association

Diabetes Treatment and ManagementDementia and Cognitive Impairment Research

Cited by 77

Insight in inpatients with schizophrenia: Relationship to symptoms and neuropsychological functioning

Zhou, Y., Rosenheck, R., Mohamed, S., Zhang, J., Chang, Q., Ou, Y., Sun, B., Ning, Y., & He, H. (2015) · Schizophrenia Research

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 47

Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China

Mohamed, S., Rosenheck, R., He, H., & Yuping, N. (2014) · Social Psychiatry and Psychiatric Epidemiology

Schizophrenia research and treatmentMental Health Treatment and Access

Cited by 26

Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge

Zhou, Y., Rosenheck, R., Mohamed, S., Ning, Y., & He, H. (2017) · Psychiatry Research

Schizophrenia research and treatmentMedication Adherence and Compliance

Cited by 23